SHAREHOLDER ALERT: Investigation of Legend Biotech Announced by Holzer & Holzer, LLCBusiness Wire • 09/21/20
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Legend Biotech Corporation and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 09/21/20
Legend Biotech Names Current Chief Financial Officer, Ying Huang, as Interim CEOBusiness Wire • 09/21/20
Legend Biotech to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare ConferenceBusiness Wire • 09/01/20
The China Center for Drug Evaluation, National Medical Products Administration Has Recommended Breakthrough Therapy Designation for ciltacabtagene autoleucel (cilta-cel, LCAR-B38M CAR-T Cells), an Investigational BCMA CAR-T Cell TherapyBusiness Wire • 08/05/20